Market Exclusive

Medidata Solutions Inc (NASDAQ:MDSO) gets upgraded to Neutral by JPMorgan Chase & Co.

Analyst Ratings For Medidata Solutions Inc (NASDAQ:MDSO)

Today, Medidata Solutions Inc (NASDAQ:MDSO) stock received an upgrade by JPMorgan Chase & Co. from Underweight to Neutral.

There are 10 Hold Ratings, 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Medidata Solutions Inc (NASDAQ:MDSO) is Hold with a consensus target price of $84.3483 per share, a potential 7.72% downside.

Some recent analyst ratings include

About Medidata Solutions Inc (NASDAQ:MDSO)
Medidata Solutions, Inc provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. Read More…

Recent Trading Activity for Medidata Solutions Inc (NASDAQ:MDSO)
Shares of Medidata Solutions Inc closed the previous trading session at 91.48 −3.27 3.45% with shares trading hands.

Exit mobile version